UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Ergebnis 16 von 485868
Datensatz exportieren als...
BibTeX
Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society
CA: a cancer journal for clinicians, 2018-07, Vol.68 (4), p.250-281
Wolf, Andrew M.D.
Fontham, Elizabeth T.H.
Church, Timothy R.
Flowers, Christopher R.
Guerra, Carmen E.
LaMonte, Samuel J.
Etzioni, Ruth
McKenna, Matthew T.
Oeffinger, Kevin C.
Shih, Ya‐Chen Tina
Walter, Louise C.
Andrews, Kimberly S.
Brawley, Otis W.
Brooks, Durado
Fedewa, Stacey A.
Manassaram‐Baptiste, Deana
Siegel, Rebecca L.
Wender, Richard C.
Smith, Robert A.
2018
Details
Autor(en) / Beteiligte
Wolf, Andrew M.D.
Fontham, Elizabeth T.H.
Church, Timothy R.
Flowers, Christopher R.
Guerra, Carmen E.
LaMonte, Samuel J.
Etzioni, Ruth
McKenna, Matthew T.
Oeffinger, Kevin C.
Shih, Ya‐Chen Tina
Walter, Louise C.
Andrews, Kimberly S.
Brawley, Otis W.
Brooks, Durado
Fedewa, Stacey A.
Manassaram‐Baptiste, Deana
Siegel, Rebecca L.
Wender, Richard C.
Smith, Robert A.
Titel
Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society
Ist Teil von
CA: a cancer journal for clinicians, 2018-07, Vol.68 (4), p.250-281
Ort / Verlag
United States: Wiley Subscription Services, Inc
Erscheinungsjahr
2018
Link zum Volltext
Quelle
Wiley Blackwell Single Titles
Beschreibungen/Notizen
In the United States, colorectal cancer (CRC) is the fourth most common cancer diagnosed among adults and the second leading cause of death from cancer. For this guideline update, the American Cancer Society (ACS) used an existing systematic evidence review of the CRC screening literature and microsimulation modeling analyses, including a new evaluation of the age to begin screening by race and sex and additional modeling that incorporates changes in US CRC incidence. Screening with any one of multiple options is associated with a significant reduction in CRC incidence through the detection and removal of adenomatous polyps and other precancerous lesions and with a reduction in mortality through incidence reduction and early detection of CRC. Results from modeling analyses identified efficient and model‐recommendable strategies that started screening at age 45 years. The ACS Guideline Development Group applied the Grades of Recommendations, Assessment, Development, and Evaluation (GRADE) criteria in developing and rating the recommendations. The ACS recommends that adults aged 45 years and older with an average risk of CRC undergo regular screening with either a high‐sensitivity stool‐based test or a structural (visual) examination, depending on patient preference and test availability. As a part of the screening process, all positive results on noncolonoscopy screening tests should be followed up with timely colonoscopy. The recommendation to begin screening at age 45 years is a qualified recommendation. The recommendation for regular screening in adults aged 50 years and older is a strong recommendation. The ACS recommends (qualified recommendations) that: 1) average‐risk adults in good health with a life expectancy of more than 10 years continue CRC screening through the age of 75 years; 2) clinicians individualize CRC screening decisions for individuals aged 76 through 85 years based on patient preferences, life expectancy, health status, and prior screening history; and 3) clinicians discourage individuals older than 85 years from continuing CRC screening. The options for CRC screening are: fecal immunochemical test annually; high‐sensitivity, guaiac‐based fecal occult blood test annually; multitarget stool DNA test every 3 years; colonoscopy every 10 years; computed tomography colonography every 5 years; and flexible sigmoidoscopy every 5 years. CA Cancer J Clin 2018;68:250–281. © 2018 American Cancer Society.
Sprache
Englisch
Identifikatoren
ISSN: 0007-9235
eISSN: 1542-4863
DOI: 10.3322/caac.21457
Titel-ID: cdi_proquest_miscellaneous_2047260066
Format
–
Schlagworte
adenoma, colonoscopy
,
Adult
,
Age
,
Age Factors
,
Aged
,
Aged, 80 and over
,
American Cancer Society
,
Cancer
,
Cancer screening
,
Colonoscopy
,
colorectal and rectal neoplasms
,
Colorectal cancer
,
Colorectal carcinoma
,
Colorectal Neoplasms - diagnosis
,
Computed tomography
,
computed tomography colonoscopy
,
Early Detection of Cancer - methods
,
Early Detection of Cancer - standards
,
Humans
,
Life expectancy
,
Life span
,
Mass Screening - methods
,
Mass Screening - standards
,
mass screening and early detection
,
Medical screening
,
Middle Aged
,
mortality
,
occult blood
,
Polyps
,
radiography
,
Risk
,
Sensitivity analysis
,
Sigmoidoscopy
,
stool testing
,
United States
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX